News from NIAID-Supported Institutions
National Institute of Allergy and Infectious Diseases sent this bulletin at 10/26/2012 10:21 AM EDTHere’s your periodic update on News from NIAID-Supported Institutions. The following links will take you to the institution’s press release:
Studies: Pigs Look Healthy But Test Positive for Flu at Fairs; Flu Transmission Seen Between Pigs and Humans
October 24, 2012—Ohio State
NIH $20 Million Transplant Grant Aims at Better Drugs, Long-Term Organ Tolerance
October 22, 2012—Emory University
PTC Therapeutics Receives $1 Million Grant Award from the National Institutes of Health (NIH) to Support Research for a Treatment for Dengue Fever
October 22, 2012—PTC Therapeutics, Inc.
New Study Discovers Unique HIV Feature
October 22, 2012—University of the Witwatersrand
Cholera Discovery Could Revolutionize Antibiotic Delivery
October 19, 2012—Simon Fraser University
Pfenex Inc. Awarded Contract by the National Institute of Allergy and Infectious Diseases (NIAID) to Develop an Alternative Delivery Method for its Recombinant Protective Antigen (rPA)-based Anthrax Vaccine
October 17, 2012—Pfenex Inc.
Emory External Research Funding Tops $500 Million for Third Year
October 17, 2012—Emory University
HIV May Leave Gut Vulnerable to Infections
October 16, 2012—Washington University School of Medicine in St. Louis
Rare Cells Regulate Immune Responses; May Offer Novel Treatment for Autoimmune Diseases
October 14, 2012—Duke University Medical Center
Researchers Uncover Molecular Basis of Infection of Tick-Transmitted Disease
October 12, 2012—Virginia Commonwealth University School of Medicine
Biologists Describe Details of New Mechanism for Molecular Interactions
These news releases were issued by organizations supported by NIAID.
Studies: Pigs Look Healthy But Test Positive for Flu at Fairs; Flu Transmission Seen Between Pigs and Humans
October 24, 2012—Ohio State
NIH $20 Million Transplant Grant Aims at Better Drugs, Long-Term Organ Tolerance
October 22, 2012—Emory University
PTC Therapeutics Receives $1 Million Grant Award from the National Institutes of Health (NIH) to Support Research for a Treatment for Dengue Fever
October 22, 2012—PTC Therapeutics, Inc.
New Study Discovers Unique HIV Feature
October 22, 2012—University of the Witwatersrand
Cholera Discovery Could Revolutionize Antibiotic Delivery
October 19, 2012—Simon Fraser University
Pfenex Inc. Awarded Contract by the National Institute of Allergy and Infectious Diseases (NIAID) to Develop an Alternative Delivery Method for its Recombinant Protective Antigen (rPA)-based Anthrax Vaccine
October 17, 2012—Pfenex Inc.
Emory External Research Funding Tops $500 Million for Third Year
October 17, 2012—Emory University
HIV May Leave Gut Vulnerable to Infections
October 16, 2012—Washington University School of Medicine in St. Louis
Rare Cells Regulate Immune Responses; May Offer Novel Treatment for Autoimmune Diseases
October 14, 2012—Duke University Medical Center
Researchers Uncover Molecular Basis of Infection of Tick-Transmitted Disease
October 12, 2012—Virginia Commonwealth University School of Medicine
Biologists Describe Details of New Mechanism for Molecular Interactions
These news releases were issued by organizations supported by NIAID.
.png)
No hay comentarios:
Publicar un comentario